Why rigorous clinical evaluations matter: strategies to boost safety and compliance

Published: 2-Apr-2025 Featured companies: NSF
Medical Devices

This white paper provides a blueprint for achieving excellence in clinical evaluations through strategic enhancements

Did you know that 40% of medical device submissions are delayed due to inadequate clinical evaluations? In the highly competitive medical device market, mastering clinical evaluations is not just a regulatory hurdle but a strategic imperative. Effective clinical evaluations can accelerate market entry, enhance brand reputation, and ensure sustained competitive superiority. This white paper provides a blueprint for achieving excellence in clinical evaluations through strategic enhancements. Through real-world case studies and actionable insights, discover how to achieve excellence and maintain a competitive edge in the medical device market.

Click here to find out why rigorous clinical evaluations matter

Featured companies

Founded in 1944, NSF’s mission is to protect and improve global human health. NSF, Pharmaceutical Services provides a comprehensive range of independent, third-party...
See more

You may also like

Regulatory

NSF launches new IVD app

Read more
This free app is full of useful resources, perfect for any IVD professional on the go

Trending Articles

  1. BSI publishes revised ISO 10993-1:2025 standard to strengthen medical device biocompatibility assessment BSI has released a revised edition of BS EN ISO 10993-1, updating the internationally recognised framework for evaluating the biological safety of medical devices in line with advances in material science, toxicology and risk management
  2. Abbott hit with multiple FDA complaints in warning letter The FreeStyle Libre manufacturer has been in the agency's line of fire after it deemed the company's response to previous letters "inadequate"
  3. BD Physioject allows self-injection of drugs for chronic diseases Disposable device offers one-button activation and needle protection after injection
  4. Schott introduces COC polymer syringe designed for cosmetic and medical applications The syringes are equipped with ergonomic container components to simplify and relieve the injection process
  5. PolarSeal opens new medical device Innovation Lab at Farnborough headquarters The new facility will aim to accelerate early-stage development and de-risk next-generation medical devices, enabling MedTech teams to move from concept to scaled products faster

Relevant companies

See more

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

You may also like

Regulatory

NSF launches new IVD app

This free app is full of useful resources, perfect for any IVD professional on the go
Manufacturing

Time to move beyond mediocre CAPAs and make them more effective

Andy Barnett, NSF, presents a white paper on CAPAs and how to make them more effective
Training & Education

Management Forum and NSF-DBA team up

To provide certification programmes to demonstrate medical device competence
Medical Devices

Biocomposites gains MDR certification for STIMULAN antibiotic carriers

Biocomposites has secured EU MDR certification for its STIMULAN Rapid Cure and STIMULAN Kit products, enabling them to be mixed with multiple Gram-positive and Gram-negative antibiotics for infection management in bone and soft tissue
Medical Devices

Abbott hit with multiple FDA complaints in warning letter

The FreeStyle Libre manufacturer has been in the agency's line of fire after it deemed the company's response to previous letters "inadequate"
Medical Devices

HiArc launches HiArc Ctrl for the acceleration of medical device development

The MedTech innovator has combined its novel PCBA LaunchBase Origin and its proprietary SDK LaunchCode to create a new, ready-to-use system, designed to accelerate the development of medical devices
Medical Devices

BSI publishes revised ISO 10993-1:2025 standard to strengthen medical device biocompatibility assessment

BSI has released a revised edition of BS EN ISO 10993-1, updating the internationally recognised framework for evaluating the biological safety of medical devices in line with advances in material science, toxicology and risk management
Subscribe now